Replimune

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Replimune and other ETFs, options, and stocks.

About REPL

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. 

CEO
Sushil Patel
CEOSushil Patel
Employees
465
Employees465
Headquarters
Woburn, Massachusetts
HeadquartersWoburn, Massachusetts
Founded
2015
Founded2015
Employees
465
Employees465

REPL Key Statistics

Market cap
955.55M
Market cap955.55M
Price-Earnings ratio
-3.07
Price-Earnings ratio-3.07
Dividend yield
Dividend yield
Average volume
3.00M
Average volume3.00M
High today
$10.93
High today$10.93
Low today
$10.55
Low today$10.55
Open price
$10.64
Open price$10.64
Volume
154.92K
Volume154.92K
52 Week high
$12.50
52 Week high$12.50
52 Week low
$1.50
52 Week low$1.50

Stock Snapshot

The current Replimune(REPL) stock price is $10.83, with a market capitalization of 955.55M. The stock trades at a price-to-earnings (P/E) ratio of -3.07.

As of 2026-07-23, Replimune(REPL) stock has fluctuated between $10.55 and $10.93. The current price stands at $10.83, placing the stock +2.6% above today's low and -0.9% off the high.

The Replimune(REPL)'s current trading volume is 154.92K, compared to an average daily volume of 3M.

In the last year, Replimune(REPL) shares hit a 52-week high of $12.50 and a 52-week low of $1.50.

In the last year, Replimune(REPL) shares hit a 52-week high of $12.50 and a 52-week low of $1.50.

REPL News

Nasdaq 1d
Replimune Group Reaches Analyst Target Price

In recent trading, shares of Replimune Group Inc (Symbol: REPL) have crossed above the average analyst 12-month target price of $10.67, changing hands for $11.0...

Replimune Group Reaches Analyst Target Price
TipRanks 3d
Replimune Group put volume heavy and directionally bearish

Bearish flow noted in Replimune (REPL) Group with 3,199 puts trading, or 1.5x expected. Most active are Sep-26 18 puts and Aug-26 8 puts, with total volume in t...

Analyst ratings

67%

of 6 ratings
Buy
33.3%
Hold
66.7%
Sell
0%

People also own

Based on the portfolios of people who own REPL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.